Gale Pollock - Covalon Technologies Director
| COV Stock | CAD 3.10 0.09 2.99% |
Director
Maj. Gen. Gale Pollock, CRNA, FACHE, FAAN., serves as Director of the Company. Pollock is a twostar general who retired in 2008 after 36 years of service in the U.S. Army. She held the position of Acting Surgeon General of the U.S. Army. Major General Pollock was the first woman and the first nonphysician to serve in this role in any of the military services of the United States. In this capacity, Major General Pollock was responsible for a worldwide 247 medical operation with a budget of 9.7 billion and a staffing complement of approximately 6500 people. Major General Pollock serves on multiple advisory boards and is the President of Pollock Associates, LLC. She is a Fellow in the American College of Healthcare Executives, the American Academy of Nursing and the National Board of Corporationrationrate Directors. In 2008, Major General Pollock established the Louis J. Fox Center for Vision Restoration and was an associate professor at the University of Pittsburgh Schools of Medicine and Nursing. In 2011, Major General Pollock became a Harvard University Fellow in their Advanced Leadership Initiative program. Major General Pollock has a Master Degree in Business, a Master Degree in Healthcare Administration and a Master Degree in National Security and Strategy. She received an Honorary Doctorate from the University of Maryland. since 2017.
| Tenure | 8 years |
| Address | 1660 Tech Avenue, Mississauga, ON, Canada, L4W 5S7 |
| Phone | 905 568 8400 |
| Web | https://www.covalon.com |
Covalon Technologies Management Efficiency
The company has return on total asset (ROA) of (0.0325) % which means that it has lost $0.0325 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0385) %, meaning that it generated substantial loss on money invested by shareholders. Covalon Technologies' management efficiency ratios could be used to measure how well Covalon Technologies manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Covalon Technologies' Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to climb to 0.08 in 2025, whereas Return On Capital Employed is likely to drop (0.22) in 2025. At this time, Covalon Technologies' Non Current Assets Total are fairly stable compared to the past year. Total Current Assets is likely to climb to about 35.1 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 127.2 K in 2025.Similar Executives
| Found 4 records | DIRECTOR Age | ||
| Peter Blecher | Microbix Biosystems | N/A | |
| Mark Cochran | Microbix Biosystems | N/A | |
| Neelu Atwal | Biosyent | N/A | |
| Joseph Renner | Microbix Biosystems | N/A | |
Management Performance
| Return On Equity | -0.0385 | ||||
| Return On Asset | -0.0325 |
Covalon Technologies Leadership Team
Elected by the shareholders, the Covalon Technologies' board of directors comprises two types of representatives: Covalon Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Covalon. The board's role is to monitor Covalon Technologies' management team and ensure that shareholders' interests are well served. Covalon Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Covalon Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Simon Smith, Chief Ltd | ||
| John Hands, Senior Director - Global Marketing | ||
| Greg Leszczynski, Vice Resources | ||
| Brent Ashton, CEO Director | ||
| Hamed Abbasian, Vice Development | ||
| Ian Brindle, Independent Director | ||
| Elaine Zhang, Vice Operations | ||
| Mark Doolittle, Senior Operations | ||
| Joseph Cordiano, Independent Director | ||
| Valerio DiTizio, Co-Founder and Chief Science Officer | ||
| Ronald Smith, Director | ||
| Gerry Arambula, President Ltd | ||
| Emily Hill, Executive CEO | ||
| Elinor Caplan, Director | ||
| Murray Miller, Independent Director | ||
| Kim Crooks, Vice President - Operations | ||
| Ron Hebert, VP Marketing | ||
| Gale Pollock, Director | ||
| Amir CFA, Executive Chairman | ||
| Jeffrey Mandel, Independent Director | ||
| Myrna Francis, Independent Director | ||
| Katie Martinovich, Interim Officer | ||
| Danny Brannagan, Chief Financial Officer | ||
| Brian Pedlar, President, Chief Executive Officer, Director | ||
| John Suk, Director | ||
| Ronald Hebert, Senior Marketing | ||
| Jason Gorel, Interim Officer | ||
| Abe Schwartz, Chairman of The Board, Advisor and Member of Audit Committee |
Covalon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Covalon Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0385 | ||||
| Return On Asset | -0.0325 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 66.62 M | ||||
| Shares Outstanding | 27.4 M | ||||
| Shares Owned By Insiders | 48.69 % | ||||
| Number Of Shares Shorted | 10.71 K | ||||
| Price To Earning | 69.86 X | ||||
| Price To Book | 3.00 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Covalon Stock Analysis
When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.